Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Abstract Fibrotic diseases cause organ failure that lead to ~45% of all deaths in the United States. Activated macrophages stimulate fibrosis by secreting cytokines that induce fibroblasts to synthesize collagen and extracellular matrix proteins. Although suppression of macrophage‐derived cytokine p...
| Published in: | EMBO Molecular Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012034 |
